Marinus Pharmaceuticals logo

Marinus Pharmaceuticals share price today

(MRNS)

Marinus Pharmaceuticals share price is $0.53 & ₹45.48 as on 7 Jan 2025, 2.30 'hrs' IST

$0.53

Market is closed - opens 8 PM, 07 Jan 2025

View live Marinus Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Marinus Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Marinus Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Marinus Pharmaceuticals share price movements

  • Today's Low: $0.53
    Today's High: $0.54

    Day's Volatility :1.85%

  • 52 Weeks Low: $0.22
    52 Weeks High: $11.26

    52 Weeks Volatility :98.04%

Marinus Pharmaceuticals Returns

PeriodMarinus Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-69.08%
-8.4%
0.0%
6 Months
-56.96%
-3.8%
0.0%
1 Year
-95.2%
-0.1%
0.0%
3 Years
-95.24%
2.9%
-19.8%

Marinus Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$0.538
Open
$0.538
Today's High
$0.54
Today's Low
$0.53
Market Capitalization
$29.5M
Today's Volume
$1.3M
52 Week High
$11.26
52 Week Low
$0.2202
Revenue TTM
$30.3M
EBITDA
$-128.7M
Earnings Per Share (EPS)
$-2.47
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2986.55%

How to invest in Marinus Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Marinus Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Marinus Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Marinus Pharmaceuticals or MRNS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Marinus Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Marinus Pharmaceuticals shares which would translate to 1.619 fractional shares of Marinus Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Marinus Pharmaceuticals, in just a few clicks!

Returns in Marinus Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Marinus Pharmaceuticals investment value today

Current value as on today

₹7,951

Returns

₹92,049

(-92.05%)

Returns from Marinus Pharmaceuticals Stock

₹95,272 (-95.27%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Marinus Pharmaceuticals

33.33%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Investment in Marinus Pharmaceuticals from India has grown in the last 30 days as on Jan 7, 2025. 33.33% more purchase transactions for Marinus Pharmaceuticals in the last 30 days versus the previous period.

-29%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Marinus Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -29% less investors are searching Marinus Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Marinus Pharmaceuticals

  • Suvretta Capital Management, LLC

    9.19%

  • Franklin Resources Inc

    8.54%

  • TANG CAPITAL MANAGEMENT LLC

    8.52%

  • Sofinnova Ventures

    7.95%

  • Vanguard Group Inc

    5.08%

  • Bain Capital Life Sciences Investors, LLC

    4.88%

Analyst Recommendation on Marinus Pharmaceuticals

Buy

    76%Buy

    23%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Marinus Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
15
15
Hold
4
2
2
Sell
0
0
0

Analyst Forecast on Marinus Pharmaceuticals

What analysts predicted

Upside of 120.75%

Current:

$0.53

Target:

$1.17

Insights on Marinus Pharmaceuticals

  • Price Movement

    In the last 1 month, MRNS stock has moved up by 86.8%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 7.19M → 8.54M (in $), with an average increase of 5.6% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -41.76M → -24.22M (in $), with an average increase of 21.3% per quarter
  • MRNS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 118.7%
  • MRNS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 150.5%
  • Price to Sales

    ForMRNS every $1 of sales, investors are willing to pay $1.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Marinus Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Marinus Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Marinus Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Marinus Pharmaceuticals Inc
80.05%
-56.96%
-95.2%
-95.24%
-93.71%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Marinus Pharmaceuticals Inc
NA
NA
0.0
-2.07
-29.87
-0.58
NA
0.31
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Marinus Pharmaceuticals Inc
Buy
$29.5M
-93.71%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Marinus Pharmaceuticals

marinus pharmaceuticals is a clinical stage biopharmaceutical company dedicated to positively impacting the well-being of patients who suffer from epilepsy and neuropsychiatric disorders. the company is in the midst of developing and commercializing ganaxolone which will treat adults and children with epileptic seizures and women with postpartum depression. on june 29, 2017, the company announced that the u.s. food and drug administration (fda) granted orphan drug designation to ganaxolone for the treatment of cdkl5 disorder. cdkl5 disorder is a severe, rare genetic disorder that affects children at an early age and causes difficult-to-control seizures and neuro-developmental impairment. currently, there are no approved therapies for children with cdkl5 disorder. orphan drug designation is granted by the fda office of orphan products development to novel drugs or biologics that treat a rare disease or condition affecting fewer than 200,000 patients in the u.s. the designation provides
Organization
Marinus Pharmaceuticals
Employees
165
CEO
Dr. Scott N. Braunstein M.D.
Industry
Health Technology

Management People of Marinus Pharmaceuticals

NameTitle
Dr. Scott N. Braunstein M.D.
CEO, President & Chairman
Mr. Steven E. Pfanstiel C.M.A., M.B.A.
COO, CFO & Treasurer
Dr. Joseph Hulihan M.D.
Chief Medical Officer
Dr. Alex Aimetti Ph.D.
Chief Scientific Officer
Ms. Sonya Weigle
Senior VP of Investor Relations, Human Resources & Corporate Affairs
Ms. Martha E. Manning Esq., J. D.
Senior VP, General Counsel & Secretary
Molly Cameron
Director of Corporate Communications & Investor Relations
Dr. Kimberly A. McCormick Pharm.D.
Chief Regulatory & Quality Assurance Officer
Ms. Christina Shafer
Chief Commercial Officer
Mr. David Czekai
Chief Chemistry, Manufacturing & Controls Officer

Important FAQs about investing in Marinus Pharmaceuticals from India :

What is Marinus Pharmaceuticals share price today?

Marinus Pharmaceuticals share price today stands at $0.53, Open: $0.54 ; Previous Close: $0.54 ; High: $0.54 ; Low: $0.53 ; 52 Week High: $11.26 ; 52 Week Low: $0.22. The stock opens at $0.54, after a previous close of $0.54. The stock reached a daily high of $0.54 and a low of $0.53, with a 52-week high of $11.26 and a 52-week low of $0.22.

Can Indians buy Marinus Pharmaceuticals shares?

Yes, Indians can invest in the Marinus Pharmaceuticals (MRNS) from India.

With INDmoney, you can buy Marinus Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Marinus Pharmaceuticals at zero transaction cost.

How can I buy Marinus Pharmaceuticals shares from India?

It is very easy to buy Marinus Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Marinus Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Marinus Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Marinus Pharmaceuticals stocks?

To start investing in Marinus Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Marinus Pharmaceuticals

Today’s highest price of Marinus Pharmaceuticals (MRNS) is $0.54.

Today’s lowest price of Marinus Pharmaceuticals (MRNS) is $0.53.

What is today's market capitalisation of Marinus Pharmaceuticals

Today's market capitalisation of Marinus Pharmaceuticals MRNS is 29.5M

What is the 52 Week High and Low Range of Marinus Pharmaceuticals

  • 52 Week High

    $11.26

  • 52 Week Low

    $0.22

What are the historical returns of Marinus Pharmaceuticals?

  • 1 Month Returns

    80.05%

  • 3 Months Returns

    -56.96%

  • 1 Year Returns

    -95.2%

  • 5 Years Returns

    -93.71%

Who is the Chief Executive Officer (CEO) of Marinus Pharmaceuticals

Dr. Scott N. Braunstein M.D. is the current Chief Executive Officer (CEO) of Marinus Pharmaceuticals.